Quoin Pharmaceuticals, Ltd. Profile Avatar - Palmy Investing

Quoin Pharmaceuticals, Ltd.

Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 …

Biotechnology
US, Ashburn [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Quoin Pharmaceuticals, Ltd. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of QNRX's Analysis
CIK: - CUSIP: 74907L102 ISIN: US74907L3006 LEI: - UEI: -
Secondary Listings
QNRX has no secondary listings inside our databases.